Advanced Cell Technology (ACTC.OB), First Patients enrolled in 2 Clinical Trials to treat Stargardt’s Disease and Dry Age Macular Degeneration
June 16th, 2011
No comments
Patients for P1/2 trials enrolled at UCLA’s Jules Stein Eye Institute Read more…
